|Technology Breakthroughs that put Metabolite Identification in the Driver’s Seat of DMPK|
On Demand Event:
In this webcast, we will present a unique perspective on the emergence of the use of metabolite identification in discovery DMPK. Over the past 5 years, this analysis has matured from a manual task performed on an ad-hoc basis and reserved for a few difficult compounds, to an intelligent and rapid scientific methodology for providing detailed information back to project teams in order to drive key decisions.
Two of the scientists that embarked upon driving this change will join us to present how this was achieved and to explain the benefits that this brought to a large pharmaceutical company and how these methods have been embraced in an innovative CRO.
We will also postulate how we can build upon these successes, and undertake the next shift in our thinking of how new technologies can change the way that drug discovery and development is performed.
LCGC North America
Dr. Philip R. Tiller
Senior Applications Specialist
Pharmaceutical & Life Sciences
IMPORTANT - PLEASE READ
This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Jamie Carpenter, email@example.com.
Register for this FREE Webcast!